Company profile
HOME - Scancell
Scancell is focused on developing innovative immunotherapies for cancer that stimulate the bodys own immune system.
Updated 06 Jun 2026 16:52
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
AP01 | Transaction MzQ0NDQxMDU2NWFkaXF6a2N4
Published 21 Nov 2024 09:31
Company registered at Companies House
1 Oct 2020 to 31 Mar 2022
Scancell have developed a fast, low cost and effective DNA vaccine which stimulates potent immune responses that can kill cancer cells and has already been shown to be safe and effective in the treatment of patients with skin cancer. This approach can also be used to develop a safe and effective vaccine to prevent infection with viruses such as the corona...
